PDB44 THE COST-EFFECTIVENESS OF SAXAGLIPTIN VERSUS SULFONYLUREA (SU) IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN GERMANY
Nov 1, 2010, 00:00 AM
10.1016/S1098-3015(11)72102-7
https://www.valueinhealthjournal.com/article/S1098-3015(11)72102-7/fulltext
Section Title :
RESEARCH POSTER ABSTRACTS
Section Order :
261
First Page :
A291
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)72102-7&doi=10.1016/S1098-3015(11)72102-7